Back to Results
First PageMeta Content
Oncolytic virus / Hepatocellular carcinoma / Medicine / JX-594 / Experimental cancer treatments


Fact Sheet Targeting, Attacking & Eradicating Cancer
Add to Reading List

Document Date: 2013-04-02 14:32:17


Open Document

File Size: 181,53 KB

Share Result on Facebook

City

San Francisco / Newport / Pusan / /

Company

American Solar Direct 1VOU / Green Cross Corporation / Bayer / Attacking & Eradicating Cancer JENNEREX INC. / Lee’s Pharmaceutical Ltd. / Three / E JX-Next Generation Private / Dendreon Corporation / Terry Hermiston / Jennerex Inc. / Geron & BiPar Sciences CO MMITTED / /

Continent

Europe / /

Country

Canada / China / South Korea / /

Currency

USD / /

/

Event

FDA Phase / /

IndustryTerm

oncolytic immunotherapy products / multi-functional products / /

MedicalCondition

advanced liver cancer / cancers / IMMUNE response stimulation Cancer / tumor / liver cancer tumor metastasis / Cancer JENNEREX / oncolytic vaccinia viruses / cancer / tumors / colorectal cancer / V LUOHUJL cancer / solid tumors / advanced primary liver cancer / liver cancer / LZ HUK RPSSZ cancer / INFECTION / /

MedicalTreatment

active immunotherapy / immunotherapy / /

Organization

Jewish General Hospital / McGill University / /

Person

Lucy Chang / Brennan R. Mulcahy / Tae-Ho Hwang / Hoyoung Huh / Ursula Fritsch / Mitchell H. Gold / David H. Kirn / Steve H. Thorne / Christopher Peetz / Hartley S. Stern / /

Position

Research Advisor & Head / Professor of Surgery / CEO / Chairman / Exec. / VP / Corporate Development Board / president and CEO / VP / Biologics Research / President / Research and Development / VP / Quality and Analytical Development Christopher Peetz / Special Advisor to the Board / Executive Chairman of the Board / VP / Regulatory Affairs / VP / VP / Quality and Analytical Development / /

Product

JX-594 / /

PublishedMedium

Nature Reviews Cancer / /

Region

South Korea / /

URL

www.jennerex.com / /

SocialTag